Updates in CAR T-Cell Therapy and Bispecific Antibodies for the Treatment of Relapsed/Refractory Multiple Myeloma

home / oncview / updates-in-car-t-cell-therapy-and-bispecific-antibodies-for-relapsed-refractory-mm

Noa Biran, MD, and David Siegel, MD, have a detailed discussion on the evolving treatment landscape in relapsed/refractory multiple myeloma.